BORIC ACID


Synonyms	Boracic acid Boric Acid Boric acid Boric acid (bh3o3) Boric acid (h(sub 3)bo(sub 3)) Boricum acidum E-284 E284 INS NO.284 INS-284 NSC-81726 Nci-c56417
Status
Molecule Category	UNKNOWN
ATC	S02AA03
UNII	R57ZHV85D4
EPA CompTox	DTXSID1020194


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	KGBXLFKZBHKPEV-UHFFFAOYSA-N
Smiles	OB(O)O
InChI	InChI=1S/BH3O3/c2-1(3)4/h2-4H

Physicochemical Descriptors

Property Name	Value
Molecular Formula	H3BO3
Molecular Weight	61.83
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Cross References

Resources	Reference
ChEBI	33118
ChEMBL	CHEMBL42403
DrugBank	DB11326
DrugCentral	3035
FDA SRS	R57ZHV85D4
Human Metabolome Database	HMDB0035731
KEGG	C12486
PDB	BO3
PubChem	7628
SureChEMBL	SCHEMBL3736
ZINC	ZINC000245189278

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).